Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Bupropion as a Smoking Cessation Aid in Alcoholics Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Bupropion as a Smoking Cessation Aid in Alcoholics conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Bupropion as a Smoking Cessation Aid in Alcoholics Clinical research trials and Bupropion as a Smoking Cessation Aid in Alcoholics medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Bupropion as a Smoking Cessation Aid in Alcoholics. Bupropion as a Smoking Cessation Aid in Alcoholics Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Bupropion as a Smoking Cessation Aid in Alcoholics clinical trial. Participants frequently obtain the most expert healthcare available for their Bupropion as a Smoking Cessation Aid in Alcoholics condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "B" Clinical Trials Conditions > Bupropion as a Smoking Cessation Aid in Alcoholics

Bupropion as a Smoking Cessation Aid in Alcoholics



Bupropion as a Smoking Cessation Aid in Alcoholics

For Condition: Smoking,Alcoholism
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Minimum Age/Maximum Age: 25 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Currently a patient in the Omaha VA Medical Center, Substance Abuse Treatment Center (SATC) or at Catholic Charities Campus for Hope. - Have a diagnosis of alcohol abuse or alcohol dependence. - Smoke 20 or more cigarettes/day (may also smoke pipes/cigars). - Be interested in quitting smoking. - Provide name, addresses, and phone numbers of at least two individuals who can provide information on their alcohol, nicotine, and other drug use during the follow-up period. - If female, patient must a) be of non-childbearing potential, b) have a negative pregnancy test, c) sign a document stating they do not plan on becoming pregnant during the study. - Agree to sign informed consent. - Able to read and understand study-related forms and procedures. Exclusion Criteria: - Advanced cardiac, pulmonary, renal, or liver disease. - History of seizures. - History of brain tumor or significant head trauma. - History of bulimia or anorexia nervosa. - Current major depressive disorder or past history of panic disorders, schizophrenia, or bipolar affective disorder. - Using psychoactive drugs. - Receiving treatment with medications that lower seizure thresholds. - Use of an investigational drug in any study in the past four weeks. - Currently using any asthma medication. - Used time-released bupropion in the past 12 months. - Currently using any other treatments to stop smoking.
Total Enrollment: 200

Location and Contact Information:

VA/Nebraska/Western Iowa Health Care System *Recruiting*
Omaha,  Nebraska,  68105
United States
Recruiting Dr.  Grant 402-977-5647


Additional Information:
Study ID Numbers:
  NIAAAGRA13689; 
Study Start Date: 
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00044434

Other Alcoholism Studies:
1. Centralized Telephone Outreach to Assist Smoking Cessation Among Veterans

2. Combinations of Pharmacologic Smoking Cessation Treatments

3. Timing of Smoking Intervention in Alcohol Treatment (nicotine patch)

4. Combination Nicotine Replacement for Alcoholic Smokers

5. Anti-Smoking Program for Parents: Effects on Child Smoking

Related Studies:

Other Alcoholism Clinical Trials
Other Nebraska Clinical Trials
Other Omaha Clinical Trials

Bupropion as a Smoking Cessation Aid in Alcoholics

Modify your Search

  Other Alcoholism Clinical Trials
  Other Nebraska Clinical Trials
  Other Omaha Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103